Lista de obras - Paolo A. Cortesi - Dominio Público Uruguay

A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases

artículo científico publicado en 2014

A systematic literature review of the economic impact of ankylosing spondylitis

artículo científico publicado el 1 de julio de 2012

About the Reliability of the Critical Review to Investigate the Generalizability of Economic Evaluations Conducted in Italy

artículo científico publicado en 2016

Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors

artículo científico publicado en 2011

Benefits in pain perception, ability function and health-related quality of life in patients with failed back surgery syndrome undergoing spinal cord stimulation in a clinical practice setting.

artículo científico publicado en 2018

Clinical epidemiology of hand eczema in patients accessing dermatological reference centres: results from Italy

artículo científico publicado en 2014

Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology

scientific article published on 12 November 2019

Compliance, persistence, costs and quality of life in young patients treated with antipsychotic drugs: results from the COMETA study

artículo científico publicado en 2013

Cost and Cost Effectiveness of Treatments for Psoriatic Arthritis: A Systematic Literature Review.

artículo científico publicado en 2018

Cost and quality of life in patients with severe chronic hand eczema refractory to standard therapy with topical potent corticosteroids

artículo científico publicado en 2013

Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis

artículo científico publicado en 2020

Cost-Effectiveness and Budget Impact of Emicizumab Prophylaxis in Haemophilia A Patients with Inhibitors

scientific article published on 30 December 2019

Cost-Effectiveness of New Direct-Acting Antivirals to Prevent Post-Liver Transplant Recurrent Hepatitis.

artículo científico publicado en 2015

Cost-Utility Analysis of Bariatric Surgery in Italy: Results of Decision-Analytic Modelling.

artículo científico publicado en 2017

Cost-effectiveness analysis of new drugs for chronic hepatitis C: the importance of updating utility values

artículo científico publicado en 2015

Cost-effectiveness analysis of oral fentanyl formulations for breakthrough cancer pain treatment

artículo científico publicado en 2017

Cost-effectiveness analysis of pharmacokinetic-driven prophylaxis vs. standard prophylaxis in patients with severe haemophilia A.

artículo científico publicado en 2016

Cost-utility analysis of biologic therapies to treat chronic plaque psoriasis in Italy: the importance of using updated and adequate social tariffs to calculate quality-adjusted life-years

artículo científico publicado en 2015

Costs and effectiveness of influenza vaccination: a systematic review

artículo científico publicado en 2018

Delisting HCV infected Liver Transplant Candidates who improved after Viral Eradication: Outcome 2 Years after Delisting.

artículo científico publicado en 2018

Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study

artículo científico publicado en 2016

Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis.

artículo científico publicado en 2016

Effective but costly: How to tackle difficult trade-offs in evaluating health improving technologies in liver diseases

artículo científico publicado en 2016

Epidemiologic and Economic Burden Attributable to First Spinal Fusion Surgery: Analysis from an Italian Administrative Database

artículo científico publicado en 2017

Epidemiology and Direct Health Care Costs of Diabetic Retinopathy: Results From a Population-Based Study.

artículo científico publicado en 2014

Feasibility, acceptability and construct validity of EQ-5D in systemic sclerosis

artículo científico publicado en 2017

Health Related Quality of Life in Chronic Liver Diseases

artículo científico publicado en 2020

Health economic models in hemophilia A and utility assumptions from a clinician's perspective

artículo científico publicado en 2015

Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study.

artículo científico publicado en 2013

Immune tolerance induction in patients with haemophilia a and inhibitors: effectiveness and cost analysis in an European Cohort (The ITER Study).

artículo científico publicado en 2015

Impact of DAAs on liver transplantation: Major effects on the evolution of indications and results. An ELITA study based on the ELTR registry

artículo científico publicado en 2018

Italian population-based values of EQ-5D health states.

artículo científico publicado en 2013

Long-term costs and outcomes in psoriatic arthritis patients not responding to conventional therapy treated with tumour necrosis factor inhibitors: the extension of the Psoriatic Arthritis Cost Evaluation (PACE) study

artículo científico publicado en 2015

Management of treatment-naïve chronic hepatitis C genotype 1 patients: a cost-effectiveness analysis of treatment options.

artículo científico publicado en 2014

Meta-analysis on incidence of inhibitors in patients with haemophilia A treated with recombinant factor VIII products.

artículo científico publicado en 2017

Modern Treatments of Haemophilia: Review of Cost-Effectiveness Analyses and Future Directions

artículo científico publicado en 2017

Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine.

artículo científico publicado en 2017

Patients', physicians', nurses', and pharmacists' preferences on the characteristics of biologic agents used in the treatment of rheumatic diseases

Reference Eq-5d-3l and Eq-5d-5l Data From the Italian General Population.

artículo científico publicado en 2014

Reply-Letter to the Editor: What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain (BTcP): Expert Opinion

artículo científico publicado en 2016

Sacubitril/valsartan in heart failure with reduced ejection fraction: cost and effectiveness in the Italian context.

artículo científico publicado en 2017

Systematic literature review on economic implications and pharmacoeconomic issues of psoriatic arthritis.

artículo científico

Systematic literature review on economic implications and pharmacoeconomic issues of rheumatoid arthritis.

artículo científico publicado en 2012

Systematic review: economic evaluations of HCV screening in the direct-acting antivirals era

scientific article published on 06 March 2019

The Burden of Severe Hypoglicaemias and Diabetes Ketoacidosis: A Population-Based Study

artículo científico publicado en 2014

The Cost-Effectiveness Of Sofosbuvir And Ribavirin Treatment In Hcv-Infected Patients Listed For Liver Transplantation

artículo científico publicado en 2014

The optimal timing of Hepatitis C therapy in liver transplant eligible patients: cost-effectiveness analysis of new opportunities.

artículo científico publicado en 2018

The rationale of pharmacoeconomic analysis in rheumatologic indications

scientific article published on 01 July 2012

The socioeconomic burden of patients affected by hemophilia with inhibitors

artículo científico publicado en 2018

Thromboembolic event rate in patients exposed to anti-inhibitor coagulant complex: a meta-analysis of 40-year published data

artículo científico publicado en 2017

Use of health-related quality-of-life measurements to estimate individuals' health on screening

artículo científico publicado en 2013

Lista de obras de Paolo A. Cortesi

A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases

A systematic literature review of the economic impact of ankylosing spondylitis

About the Reliability of the Critical Review to Investigate the Generalizability of Economic Evaluations Conducted in Italy

Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors

Benefits in pain perception, ability function and health-related quality of life in patients with failed back surgery syndrome undergoing spinal cord stimulation in a clinical practice setting.

Clinical epidemiology of hand eczema in patients accessing dermatological reference centres: results from Italy

Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology

Compliance, persistence, costs and quality of life in young patients treated with antipsychotic drugs: results from the COMETA study

Cost and Cost Effectiveness of Treatments for Psoriatic Arthritis: A Systematic Literature Review.

Cost and quality of life in patients with severe chronic hand eczema refractory to standard therapy with topical potent corticosteroids

Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis

Cost-Effectiveness and Budget Impact of Emicizumab Prophylaxis in Haemophilia A Patients with Inhibitors

Cost-Effectiveness of New Direct-Acting Antivirals to Prevent Post-Liver Transplant Recurrent Hepatitis.

Cost-Utility Analysis of Bariatric Surgery in Italy: Results of Decision-Analytic Modelling.

Cost-effectiveness analysis of new drugs for chronic hepatitis C: the importance of updating utility values

Cost-effectiveness analysis of oral fentanyl formulations for breakthrough cancer pain treatment

Cost-effectiveness analysis of pharmacokinetic-driven prophylaxis vs. standard prophylaxis in patients with severe haemophilia A.

Cost-utility analysis of biologic therapies to treat chronic plaque psoriasis in Italy: the importance of using updated and adequate social tariffs to calculate quality-adjusted life-years

Costs and effectiveness of influenza vaccination: a systematic review

Delisting HCV infected Liver Transplant Candidates who improved after Viral Eradication: Outcome 2 Years after Delisting.

Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study

Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis.

Effective but costly: How to tackle difficult trade-offs in evaluating health improving technologies in liver diseases

Epidemiologic and Economic Burden Attributable to First Spinal Fusion Surgery: Analysis from an Italian Administrative Database

Epidemiology and Direct Health Care Costs of Diabetic Retinopathy: Results From a Population-Based Study.

Feasibility, acceptability and construct validity of EQ-5D in systemic sclerosis

Health Related Quality of Life in Chronic Liver Diseases

Health economic models in hemophilia A and utility assumptions from a clinician's perspective

Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study.

Immune tolerance induction in patients with haemophilia a and inhibitors: effectiveness and cost analysis in an European Cohort (The ITER Study).

Impact of DAAs on liver transplantation: Major effects on the evolution of indications and results. An ELITA study based on the ELTR registry

Italian population-based values of EQ-5D health states.

Long-term costs and outcomes in psoriatic arthritis patients not responding to conventional therapy treated with tumour necrosis factor inhibitors: the extension of the Psoriatic Arthritis Cost Evaluation (PACE) study

Management of treatment-naïve chronic hepatitis C genotype 1 patients: a cost-effectiveness analysis of treatment options.

Meta-analysis on incidence of inhibitors in patients with haemophilia A treated with recombinant factor VIII products.

Modern Treatments of Haemophilia: Review of Cost-Effectiveness Analyses and Future Directions

Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine.

Patients', physicians', nurses', and pharmacists' preferences on the characteristics of biologic agents used in the treatment of rheumatic diseases

Reference Eq-5d-3l and Eq-5d-5l Data From the Italian General Population.

Reply-Letter to the Editor: What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain (BTcP): Expert Opinion

Sacubitril/valsartan in heart failure with reduced ejection fraction: cost and effectiveness in the Italian context.

Systematic literature review on economic implications and pharmacoeconomic issues of psoriatic arthritis.

Systematic literature review on economic implications and pharmacoeconomic issues of rheumatoid arthritis.

Systematic review: economic evaluations of HCV screening in the direct-acting antivirals era

The Burden of Severe Hypoglicaemias and Diabetes Ketoacidosis: A Population-Based Study

The Cost-Effectiveness Of Sofosbuvir And Ribavirin Treatment In Hcv-Infected Patients Listed For Liver Transplantation

The optimal timing of Hepatitis C therapy in liver transplant eligible patients: cost-effectiveness analysis of new opportunities.

The rationale of pharmacoeconomic analysis in rheumatologic indications

The socioeconomic burden of patients affected by hemophilia with inhibitors

Thromboembolic event rate in patients exposed to anti-inhibitor coagulant complex: a meta-analysis of 40-year published data

Use of health-related quality-of-life measurements to estimate individuals' health on screening